anonymous
Guest
anonymous
Guest
Will GSK management be able to show that a bird in Unilever’s in worth less than two in CET’s hand? If this can happen to CX than it will most definitely happen to RX. The demerger should have been long over by now so “dems da breaks for dragging it out.